Literature DB >> 17763633

[Proposals for designing the food chain information for the implementation of the risk-oriented ante- and post-mortem meat inspection].

T Blaha1, D Meemken, C P Dickhaus, G Klein.   

Abstract

The recent crises in the meat industry due to meat-associated risks such as salmonella, nitrofen and dioxin prove that the traditional ante- and post mortem inspection of slaughter animals and carcasses is not any longer able to recognise and prevent the risks of today. Therefore, the EU Commission has issued Reg. (EC) 853/2004 and Reg. (EC) 854/2004 that regulate the transition of the traditional meat inspection, which demands inspecting each individual carcass in the same way, to a risk-based meat inspection, which is using relevant pieces of information about the previous production stages for making risk-based decisions on the intensity of the inspection of slaughter pig batches. The new EU legislation is not any longer prescribing exactly the inspection procedure, but defines the food safety goals. The consequence is that there are still various ideas and opinions on how to implement a reasonable risk-based meat inspection, and, in particular, on how to design the "relevant food chain information". The present paper is describing the legal framework and the objectives of the risk-based meat inspection, and proposals for designing the food chain information for the implementation of the risk-based ante- and post-mortem meat inspection are made and discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17763633

Source DB:  PubMed          Journal:  Dtsch Tierarztl Wochenschr        ISSN: 0341-6593


  1 in total

1.  Feasibility study of veterinary antibiotic consumption in Germany--comparison of ADDs and UDDs by animal production type, antimicrobial class and indication.

Authors:  Roswitha Merle; Matthias Robanus; Christine Hegger-Gravenhorst; Yvonne Mollenhauer; Peter Hajek; Annemarie Käsbohrer; Walther Honscha; Lothar Kreienbrock
Journal:  BMC Vet Res       Date:  2014-01-08       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.